Article
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial.
British journal of cancer - 1 Nov 2024
Torr Bethany, Jones Christopher, Kavanaugh Grace, Hamill Monica, Allen Sophie, Choi Subin, Garrett Alice, Valganon-Petrizan Mikel, MacMahon Suzanne, Yuan Lina, Way Rosalind, Harder Helena, Gold Rochelle, Taylor Amy, Gabe Rhian, Lucassen Anneke, Manchanda Ranjit, Fallowfield Lesley, Jenkins Valerie, Gandhi Ashu, Evans D Gareth, George Angela, Hubank Michael, Kemp Zoe, Bremner Stephen, Turnbull Clare
Abstract excerpt
BACKGROUND: Genetic testing to identify germline high-risk pathogenic variants in breast cancer susceptibility genes is increasingly part of the breast cancer diagnostic pathway. Novel patient-centred pathways may offer opportunity to expand capacity and reduce turnaround time. METHODS: We recruited 1140 women with unselected breast cancer to undergo germline genetic testing through the BRCA-DIRECT pathway (which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
